{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T03:01:09Z","timestamp":1774321269269,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.hrtlng.2022.04.008","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T14:02:57Z","timestamp":1651068177000},"page":"68-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical profile and predictors of 30-day all-cause mortality of ST-elevation myocardial infarction (STEMI) patients receiving fibrinolytic therapy in an Asian population"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2676-7755","authenticated-orcid":false,"given":"Hock Peng","family":"Koh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8125-8462","authenticated-orcid":false,"given":"Adyani","family":"Md Redzuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamin","family":"Mohd Saffian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jivanraj R.","family":"Nagarajah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel Thomas","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasnita","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2022.04.008_bib0001","unstructured":"World Health Organization. The top 10 causes of death; 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death. Accessed 12 November 2020."},{"issue":"37","key":"10.1016\/j.hrtlng.2022.04.008_bib0002","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/eurheartj\/ehu268","article-title":"The history of coronary reperfusion","volume":"35","author":"Van de Werf","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrtlng.2022.04.008_bib0003","unstructured":"Ministry of Health Malaysia: Putrajaya; 2019. Clinical practice guidelines: management of acute st-segment elevation myocardial infarction (STEMI). Available from: https:\/\/www.moh.gov.my\/index.php\/pages\/view\/133. Accessed 15 November 2020."},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.008_bib0004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ehjqcco\/qcaa057","article-title":"Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysis","volume":"7","author":"Tern","year":"2021","journal-title":"Eur Hear J. Qual Care Clin outcomes"},{"issue":"5","key":"10.1016\/j.hrtlng.2022.04.008_bib0005","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.21037\/cdt-20-398","article-title":"Prevalence and predictors associated with in-hospital mortality in acute ST segment elevation myocardial infarction after reperfusion therapy in developing country","volume":"10","author":"Wichian","year":"2020","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.hrtlng.2022.04.008_bib0006","unstructured":"Wan Ahmad WA. National cardiovascular disease database (NCVD): annual report of the acute coronary syndrome (ACS) 2014-2015; 2017. Available from: http:\/\/www.acrm.org.my\/ncvd. Accessed 17 October 2020."},{"issue":"13","key":"10.1016\/j.hrtlng.2022.04.008_bib0007","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/CIRCULATIONAHA.108.804880","article-title":"Public reporting of 30-day mortality for patients hospitalized with acute myocardial infarction and heart failure","volume":"118","author":"Krumholz","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.008_bib0008","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge","volume":"76","author":"Chesebro","year":"1987","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.008_bib0009","doi-asserted-by":"crossref","first-page":"122","DOI":"10.21315\/mjms2018.25.4.12","article-title":"Sample size guidelines for logistic regression from observational studies with large population: emphasis on the accuracy between statistics and parameters based on real life clinical data","volume":"25","author":"Bujang","year":"2018","journal-title":"Malays J Med Sci"},{"issue":"2","key":"10.1016\/j.hrtlng.2022.04.008_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/1995-705X.99224","article-title":"Clinical profile and mortality of ST-segment elevation myocardial- infarction patients receiving thrombolytic -therapy in the Middle East","volume":"13","author":"Panduranga","year":"2012","journal-title":"Hear Views"},{"issue":"8971","key":"10.1016\/j.hrtlng.2022.04.008_bib0011","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0140-6736(95)92224-5","article-title":"Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison Of Thrombolytics","volume":"346","author":"Wilcox","year":"1995","journal-title":"Lancet"},{"issue":"8478","key":"10.1016\/j.hrtlng.2022.04.008_bib0012","first-page":"397","article-title":"Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction","volume":"327","year":"1986","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.hrtlng.2022.04.008_bib0013","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","article-title":"A comparison of reteplase with alteplase for acute myocardial infarction","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"issue":"9180","key":"10.1016\/j.hrtlng.2022.04.008_bib0014","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","article-title":"Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial","volume":"354","author":"Van de Werf","year":"1999","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.hrtlng.2022.04.008_bib0015","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hrtlng.2022.04.008_bib0016","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.hrtlng.2022.04.008_bib0017","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.amjcard.2013.07.037","article-title":"Trends in myocardial infarction rates and case fatality by anatomical location in four united states communities, 1987 to 2008 (from the atherosclerosis risk in communities study)","volume":"112","author":"Newman","year":"2013","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.hrtlng.2022.04.008_bib0018","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0003319717730168","article-title":"Higher risk of bleeding in Asians presenting with ST-segment elevation myocardial infarction: analysis of the national inpatient sample database","volume":"69","author":"Misumida","year":"2018","journal-title":"Angiology"},{"issue":"5","key":"10.1016\/j.hrtlng.2022.04.008_bib0019","first-page":"381","article-title":"Association of risk factors and its bleeding complication for tenecteplase administered in acute myocardial infarction (AMI)","volume":"68","author":"Nik Muhamad","year":"2013","journal-title":"Med J Malays"},{"issue":"7","key":"10.1016\/j.hrtlng.2022.04.008_bib0020","doi-asserted-by":"crossref","first-page":"e40249","DOI":"10.1371\/journal.pone.0040249","article-title":"An Asian validation of the TIMI risk score for ST-segment elevation myocardial infarction","volume":"7","author":"Selvarajah","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.008_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46486-0","article-title":"Independent predictors of cardiac mortality and hospitalization for heart failure in a multi-ethnic Asian ST-segment elevation myocardial infarction population treated by primary percutaneous coronary intervention","volume":"9","author":"Bulluck","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.hrtlng.2022.04.008_bib0022","first-page":"238","article-title":"Predictors of 30-day mortality in ST-elevation myocardial infarction (STEMI) patients","volume":"51","author":"Ginanjar","year":"2019","journal-title":"Acta Med Indones"},{"issue":"6","key":"10.1016\/j.hrtlng.2022.04.008_bib0023","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/clc.4960020612","article-title":"The prognosis of anterior myocardial infarction revisited: a community-wide study","volume":"2","author":"Kennedy","year":"1979","journal-title":"Clin Cardiol"},{"issue":"16","key":"10.1016\/j.hrtlng.2022.04.008_bib0024","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1001\/jama.290.16.2174","article-title":"Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification","volume":"290","author":"Khot","year":"2003","journal-title":"J Am Med Assoc"},{"issue":"10096","key":"10.1016\/j.hrtlng.2022.04.008_bib0025","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(17)31441-1","article-title":"Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis","volume":"390","author":"Jinatongthai","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.hrtlng.2022.04.008_bib0026","doi-asserted-by":"crossref","first-page":"556","DOI":"10.7326\/0003-4819-132-7-200004040-00008","article-title":"Identification and management of patients with failed thrombolysis after acute myocardial infarction","volume":"132","author":"Goldman","year":"2000","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.hrtlng.2022.04.008_bib0027","first-page":"511","article-title":"The bleeding risk score as a mortality predictor in patients with acute coronary syndrome","volume":"101","author":"Nicolau","year":"2013","journal-title":"Arq Bras Cardiol"},{"issue":"4","key":"10.1016\/j.hrtlng.2022.04.008_bib0028","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/157340312803760857","article-title":"Atrial fibrillation in acute ST-elevation myocardial infarction: clinical and prognostic features","volume":"8","author":"Gorenek","year":"2012","journal-title":"Curr Cardiol Rev"},{"issue":"1","key":"10.1016\/j.hrtlng.2022.04.008_bib0029","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1515\/med-2017-0018","article-title":"Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction","volume":"12","author":"Vukmirovi\u0107","year":"2017","journal-title":"Open Med"},{"key":"10.1016\/j.hrtlng.2022.04.008_bib0030","unstructured":"Department of Statistics Malaysia. Statistics on causes of death, Malaysia; 2020. Available from: https:\/\/www.dosm.gov.my\/v1\/index.php?r=column\/cthemeByCat&cat=401&bul_id=QTU5T0dKQ1g4MHYxd3ZpMzhEMzdRdz09&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09. Accessed 1 December 2020."}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956322000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956322000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:39:32Z","timestamp":1758955172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956322000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"alternative-id":["S0147956322000887"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2022.04.008","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical profile and predictors of 30-day all-cause mortality of ST-elevation myocardial infarction (STEMI) patients receiving fibrinolytic therapy in an Asian population","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2022.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}